Heparanase Inhibition for Organ Preservation05953HPSE inhibitors added to ex vivo lung perfusion preserve endothelial glycocalyx, boost graft quality and transplant outcomes. (15 words)Technology TypeTherapeutic ModalityTechnology SubtypeSmall MoleculeTherapeutic AreasImmunologyLead InventorPablo SanchezDepartmentMed-Cardiothoracic SurgeryAll Tech InnovatorsKentaro NodaPablo Gerardo SanchezDate Submitted2022-02-03
Novel Compounds to Inhibit TNF-Induced NF-κB Pathways04864Network-centric discovery yields two first-in-class small molecules selectively blocking TNF-induced NF-κB signaling, reducing off-target effects.Technology TypeTherapeutic ModalityTechnology SubtypeSmall MoleculeTherapeutic AreasImmunologyTagsAutoimmuneLead InventorCarlos CamachoDepartmentMed-Computational and Systems BiologyAll Tech InnovatorsCarlos Jaime CamachoRobin E C LeeDate Submitted2019-01-22
B Cell-Based Biomarker for Detecting Acute Renal Transplant Rejection06574A blood test using B cell markers and machine learning detects acute renal transplant rejection noninvasively with high accuracy.Technology TypeDiagnostic/AssayTechnology SubtypeBiomarkerTherapeutic AreasImmunologyNephrologyTherapeutic IndicationsOtherLead InventorDavid RothsteinDepartmentMed-SurgeryAll Tech InnovatorsAravind CherukuriDavid Mark RothsteinDate Submitted2023-11-27
NAMPT Inhibitors Exhibit Excellent Potency and ADME Properties05522Novel Nampt inhibitors deliver strong potency and favorable ADME, enabling chemotherapy and immune support benefits.Technology TypeTherapeutic ModalityTechnology SubtypeSmall MoleculeTherapeutic AreasImmunologyOncologyTagsAutoimmuneImmuno-oncologyLead InventorBeibei ChenDepartmentMed-MedicineAll Tech InnovatorsBeibei ChenToren FinkelYuan LiuTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2020-10-06
Novel Mouse Model for Immune-Related Adverse Events06884Non-genetic mouse model mimics immunotherapy irAEs across gut, liver, skin via diet/microbiome changes; versatile, human-relevant, safe for KO systems.Technology TypeLife Science Research ToolTechnology SubtypeAnimal ModelTherapeutic AreasImmunologyTherapeutic IndicationsInflammation - GeneralTagsAutoimmuneImmuno-oncologyPlatform TechnologyLead InventorAbigail OveracreDepartmentMed-ImmunologyAll Tech InnovatorsGreg M. DelgoffeAbigail Elise OveracreDipyaman PatraTechnology Readiness Level4. Prototype testing and refinementDate Submitted2024-09-19
Delivery of Antagonists and Agonists for Immune Modulation06543Controlled microparticle release delivers ATP antagonists and adenosine receptor agonists to suppress inflammation long-term.Technology TypeTherapeutic ModalityTechnology SubtypeDrug Delivery / FormulationTherapeutic AreasImmunologyDermatologyTherapeutic IndicationsDermatitisLead InventorElizabeth BentleyDepartmentBioengineeringAll Tech InnovatorsStephen C. BalmertElizabeth BentleyJulie KobyraTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2023-10-17
A Novel Approach to Treating Autoimmune Diseases by Modulating Immune Cell Proliferation07129Inhibits PIKFYVE to boost Treg cells, lowering Th17-driven autoimmunity and restoring immune balance.Technology TypeTherapeutic ModalityTechnology SubtypeDrug Discovery - TargetTherapeutic AreasImmunologyNeuroscienceTherapeutic IndicationsMultiple Sclerosis (MS)Autoimmune encephalitis (AIE)TagsAutoimmunePlatform TechnologyPersonalized MedicineLead InventorWilliam HawseDepartmentMed-ImmunologyAll Tech InnovatorsWilliam F. HawseTechnology Readiness Level4. Pre-clinical developmentDate Submitted2025-03-27
Novel Patient-Derived Assembloid Model Accelerates Immunotherapy Development for Difficult-to-Treat Cancers06922Patient-derived assembloid with tumor-immune co-cultures accelerates immunotherapy/vaccine development for hard-to-treat head and neck cancers.Technology TypeLife Science Research ToolTechnology SubtypeCell LineTherapeutic AreasImmunologyOncologyTherapeutic IndicationsSolid tumorTagsImmuno-oncologyTissue engineeringPlatform TechnologyLead InventorRiyue BaoDepartmentMed-MedicineAll Tech InnovatorsRiyue BaoJason J. LukeTechnology Readiness Level3. Prototype developmentDate Submitted2024-10-16
Novel Llama Nanobody to Treat HIV-106827Humanized llama nanobody 4E2 neutralizes diverse HIV-1 variants, mimicking CD4 with low immunogenicity, promising therapy.Technology TypeTherapeutic ModalityTechnology SubtypeAntibody - mAbTherapeutic AreasImmunologyInfectious DiseaseTherapeutic IndicationsHIVTagsDrug Discovery - TargetLife ScienceLead InventorWei LiDepartmentMed-MedicineAll Tech InnovatorsZhiwei FengMargaret Grace HinesWei LiDate Submitted2024-07-26CollectionsWomen's & Reproductive HealthHealthcare AI
Novel Small Molecules for Inhibition of MALT105186Innovative MALT1 inhibitors block both protease and scaffolding functions, expanding cancer and autoimmune therapy potential.Technology TypeTherapeutic ModalityTechnology SubtypeSmall MoleculeTherapeutic AreasImmunologyOncologyTagsAutoimmuneImmuno-oncologyLead InventorPeter LucasDepartmentMed-PathologyAll Tech InnovatorsBeibei ChenDong HuHeejae KangTechnology Readiness Level2. Initial proof of concept, in-vitroDate Submitted2019-11-30CollectionsWomen's & Reproductive Health
Eomesodermin as a Biomarker for Allograft Rejection03456Eomesodermin as a noninvasive biomarker predicts transplant rejection risk by monitoring memory T cell activity to guide therapy.Technology TypeDiagnostic/AssayTechnology SubtypeBiomarkerTherapeutic AreasImmunologySurgeryTherapeutic IndicationsOtherLead InventorMohamed EzzelarabDepartmentMed-SurgeryAll Tech InnovatorsMohamed Borhami EzzelarabAngus W. ThomsonDate Submitted2014-11-25
FSTL-1: a Novel Target for Inflammation01185FSTL-1 is a novel proinflammatory target in arthritis; blocking it may reduce inflammation with new therapies.Technology TypeTherapeutic ModalityTechnology SubtypeDrug Discovery - TargetTherapeutic AreasImmunologyTherapeutic IndicationsRheumatoid arthritisInflammation - GeneralLead InventorRaphael HirschDepartmentMed-PediatricsAll Tech InnovatorsRaphael HirschAnthony D. MarinovTakakao MiyamaeTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2005-11-29
Targeted Treatment of Inflammatory Bowel Disease05417Orally delivered, targeted PLGA microparticles deliver IL-2, TGF-β, and rapamycin to inflamed gut tissue, reducing IBD activity.Technology TypeTherapeutic ModalityTechnology SubtypeDrug Delivery / FormulationTherapeutic AreasImmunologyGastroenterologyTherapeutic IndicationsChrohn's DiseaseLead InventorRoger SandsDepartmentMed-MedicineAll Tech InnovatorsSteven R. LittleRoger Warren SandsTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2020-06-11
Novel Biomarker to Detect CMV T Cell Immunity04855KLRG1-based assay predicts CMV T cell immunity in transplant patients, enabling targeted antiviral therapy.Technology TypeDiagnostic/AssayTechnology SubtypeBiomarkerTherapeutic AreasImmunologyInfectious DiseaseLead InventorJohn McDyerDepartmentMed-MedicineAll Tech InnovatorsAkihiko HojiJohn Francis McDyerIulia-Dana PopescuDate Submitted2019-01-09
Functional Poly(Hydrosiloxane)-Based Microbial Nanoculture Systems04723Functional PDMS-based microbial nanocultures enhance permeability and mechanical strength for safer, in-situ microbial studies.Technology TypeEngineering TechnologyTechnology SubtypeMaterial ScienceTherapeutic AreasImmunologyTagsBiomaterialPlatform TechnologyLead InventorTagbo NiepaDepartmentChem/Petroleum EngineeringAll Tech InnovatorsShanna-Leigh DavidsonTagbo Herman Roland NiepaDate Submitted2018-08-29
Novel Mouse Models for Study of Tim-3 Signaling04696CRISPR-edited mice express truncated Tim-3 on immune cells only, in C57BL/6 background, enabling precise signaling studies.Technology TypeLife Science Research ToolTechnology SubtypeAnimal ModelTherapeutic AreasImmunologyLead InventorLawrence KaneDepartmentMed-ImmunologyAll Tech InnovatorsLawrence Patrick KaneDate Submitted2018-08-01
Anti-HLA-A mAbs LGIII-147.4.1 and Hybridoma Cell Line01827Monoclonal antibody LGIII-147.4.1 targets HLA-A2, enabling selective immune recognition for research tools and MHC studies.Technology TypeLife Science Research ToolTechnology SubtypeCell LineTherapeutic AreasImmunologyLead InventorSoldano FerroneDepartmentDepartment of SurgeryAll Tech InnovatorsSoldano FerroneDate Submitted2008-09-04
Novel Therapy to Prevent Organ Transplant Rejection06909WS6 inhibitor targets tissue-resident memory T cells, potentially preventing organ transplant rejection with reduced broad immunosuppression.Technology TypeTherapeutic ModalityTechnology SubtypeSmall MoleculeTherapeutic AreasImmunologyTherapeutic IndicationsOtherTagsDrug Discovery - TargetLife ScienceLead InventorKhodor Abou DayaDepartmentMed-SurgeryAll Tech InnovatorsKhodor Abou DayaDate Submitted2024-10-01
MicFly: Rapid, Single-Cell Phenotyping and Absolute Quantification of Bacterial Microbiota06270MicFly integrates surface antibody binding with HCR-based DNA/RNA identity in single bacteria via flow cytometry for absolute quantification.Technology TypeDiagnostic/AssayTechnology SubtypeIn vitro DiagnosticTherapeutic AreasImmunologyGastroenterologyTherapeutic IndicationsInflammatory bowel diseaseInflammation - GeneralChrohn's DiseaseTagsPediatricsPrecision medicineCritical CareLead InventorTimothy HandDepartmentMed-PediatricsAll Tech InnovatorsDarryl A. AbbottWilliam H. DePasTimothy Wesley HandDate Submitted2023-01-23
Novel Human Antibodies Targeting ENPP105859Novel fully human anti-ENPP1 antibodies offer targeted cancer immunotherapy potential, compatible with BiTE, CAR-T, and ADC strategies.Technology TypeTherapeutic ModalityTechnology SubtypeAntibody - mAbTherapeutic AreasImmunologyOncologyTherapeutic IndicationsDuctal carcinoma (Breast cancer)Solid tumorLung cancer - otherTagsImmuno-oncologyLead InventorDimiter DimitrovAll Tech InnovatorsDusan BaekXiaojie ChuDimiter Stanchev DimitrovTechnology Readiness Level2. Initial proof of concept, in-vitroDate Submitted2021-10-30CollectionsWomen's & Reproductive Health
Genetic Re-engineering of Immune Cells to Improve Metabolic Fitness for Immunotherapy03881Engineered CAR T cells boosted by mitochondrial biogenesis genes to enhance metabolic resilience for solid-tumor immunotherapy.Technology TypeTherapeutic ModalityTechnology SubtypeCell Therapy - T CellTherapeutic AreasImmunologyOncologyTherapeutic IndicationsSolid tumorTagsImmuno-oncologyLead InventorGreg DelgoffeDepartmentMed-ImmunologyAll Tech InnovatorsGreg M. DelgoffeTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2016-03-30CollectionsCell & Gene Therapy
Novel Biomarker for Peridontal Disease07268Saliva-based sTREM2 biomarker enables noninvasive early detection of periodontal disease, guiding implant/surgical decisions.Technology TypeDiagnostic/AssayTechnology SubtypeBiomarkerTherapeutic AreasImmunologyTherapeutic IndicationsInflammation - GeneralTagsBiomarkerIn Vitro DiagnosticLife ScienceLead InventorDaniel ClarkDepartmentDent Med-Periodontics/Preventive DentistryAll Tech InnovatorsTharick Ali PascoalDaniel Robert ClarkDate Submitted2025-07-29CollectionsRegenerative MedicineWomen's & Reproductive Health
pH-Sensitive Linkers for Advanced Biomedical Delivery07192Acid-cleavable beta-diketone/triketone linkers enable bioorthogonal delivery systems for mRNA, gene therapy, and targeted cancer therapeutics.Technology TypeTherapeutic ModalityTechnology SubtypeDrug Delivery / FormulationTherapeutic AreasImmunologyOncologyTherapeutic IndicationsSolid tumorTagsPolymerPlatform TechnologyLead InventorSong LiDepartmentPharm-Pharmaceutical ScienceAll Tech InnovatorsYixian HuangSong LiHuatian LiTechnology Readiness Level2. Initial proof of concept, in-vitroDate Submitted2025-05-23
T Cell Receptors Targeting Mutations in RNA Splicing Factors04989Engineered TCRs target mutated RNA splicing factors across cancers, offering personalized immunotherapy with no reactivity to normal proteins.Technology TypeTherapeutic ModalityTechnology SubtypeCell Therapy - T CellTherapeutic AreasImmunologyOncologyTherapeutic IndicationsOcular/ uveal melanomaChronic Lymphocytic Leukemia (CLL)Ductal carcinoma (Breast cancer)TagsImmuno-oncologyLead InventorUdai KammulaDepartmentMed-SurgeryAll Tech InnovatorsChetana BhaskarlaUdai Shankar KammulaGhanshyam Singh YadavTechnology Readiness Level2. Initial proof of concept, in-vitroDate Submitted2019-05-10CollectionsCell & Gene TherapyWomen's & Reproductive Health
Models of DNA Mismatch Repair Deficiency05460CRISPR-induced MLH1 inactivation creates immunogenic, MSI colorectal tumor models to study apoptosis-driven anti-tumor immunity and immunotherapy.Technology TypeLife Science Research ToolTechnology SubtypeNucleic AcidTherapeutic AreasImmunologyOncologyLead InventorLin ZhangDepartmentMed-Pharmacology and Chemical BiologyAll Tech InnovatorsJian YuLin ZhangDate Submitted2020-07-28
My Voice: Empowering Reproductive Health Decisions in Rheumatology05402A mobile web-based decision aid, MyVoice, helps women with rheumatic diseases plan pregnancy via personalized, patient-provider collaboration.Technology TypeDigital HealthTechnology SubtypeClinical Decision SupportTherapeutic AreasImmunologyReproductive HealthTherapeutic IndicationsRheumatoid arthritisOtherContraceptionTagsWomen's HealthLead InventorMehret TalabiDepartmentMed-MedicineAll Tech InnovatorsMehret Selas Birru TalabiDate Submitted2020-06-03CollectionsWomen's & Reproductive Health
Dual-Action Kinase Modulators: A Novel Therapeutic Class for Cancer and Fibrotic Diseases03268Dual-action kinase modulators activate AMPK and inhibit EMT drivers (Hippo, Wnt, TGF-β), suppressing cancer and fibrosis.Technology TypeTherapeutic ModalityTechnology SubtypeSmall MoleculeTherapeutic AreasImmunologyOncologyTagsImmuno-oncologyLead InventorAbdelhadi RebbaaDepartmentMed-PathologyAll Tech InnovatorsSebastien ComesseAdam DaichMartin LawsonTechnology Readiness Level5. Drug candidate createdDate Submitted2014-03-12
Tlr4 Knockout Rats03363A novel Tlr4 knockout rat model enables enhanced immune and neurological research, offering translational advantages over mice.Technology TypeLife Science Research ToolTechnology SubtypeAnimal ModelTherapeutic AreasImmunologyNeuroscienceLead InventorGregg HomanicsDepartmentMed-Anesthesiology and Perioperative MedicineAll Tech InnovatorsGregg E. Homanics PhDDate Submitted2014-07-16
Novel Treatment for Dry Eye Disease05988IL-4 eye drops target inflammation and goblet cell dysfunction in dry eye disease, aiming for lasting tear film stability.Technology TypeTherapeutic ModalityTechnology SubtypeDrug Delivery / FormulationTherapeutic AreasImmunologyOphthalmologyTagsBiomaterialLead InventorAlexis NolfiDepartmentOffice of the SVC and ProvostAll Tech InnovatorsBryan Nicklaus BrownVishal JhanjiMangesh KulkarniTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2022-03-18
Peptide-Dragged Mitochondria-Targeted Electron Scavengers as Novel Anti-Inflammatory Agents01530Mitochondria-targeted antioxidant peptides scavenge radicals to quell inflammation, offering a potent, novel anti-inflammatory therapy.Technology TypeTherapeutic ModalityTechnology SubtypeSmall MoleculeTherapeutic AreasImmunologyTherapeutic IndicationsInflammation - GeneralLead InventorMitchell FinkDepartmentMed-Critical Care MedicineAll Tech InnovatorsMitchell Phillip Fink MDDate Submitted2007-06-21
4 Pillars™ Practice Transformation Program033724 Pillars™ Practice Transformation boosts outpatient immunization rates via four-domain, dashboard-guided, evidence-based implementation.Technology TypeDigital HealthTechnology SubtypeHealthcare DeliveryTherapeutic AreasImmunologyTagsConsumerLead InventorRichard ZimmermanDepartmentMed-Family MedicineAll Tech InnovatorsMary Patricia NowalkJonathan Marc RaviottaRichard K. ZimmermanDate Submitted2014-07-29
Use of Glitazone Compounds to Improve Ex-Vivo Expansion of Tumor-Infiltrating Lymphocytes03858PPARγ agonists restore mitochondrial biogenesis in exhausted tumor T cells, boosting ex‑vivo TIL expansion for therapy.Technology TypeTherapeutic ModalityTechnology SubtypeCell Therapy - T CellTherapeutic AreasImmunologyOncologyTagsImmuno-oncologyLead InventorGreg DelgoffeDepartmentMed-ImmunologyAll Tech InnovatorsGreg M. DelgoffeTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2016-03-16CollectionsCell & Gene Therapy
Modeling Wound Healing01265Agent-based in silico wound-healing model simulates inflammation, tissue damage, and therapies for personalized clinical predictions.Technology TypeLife Science Research ToolTechnology SubtypeBioinformaticsTherapeutic AreasImmunologyIntensive CareTherapeutic IndicationsTraumaTagsImmuno-oncologyRegenerative medicineLead InventorYoram VodovotzDepartmentMed-SurgeryAll Tech InnovatorsGilles ClermontPatricia Ann Hebda Ph.D.Yee Key LiDate Submitted2006-05-10CollectionsRegenerative Medicine
A Novel Tool for Measuring Quality of Life in Pediatric Localized Scleroderma (SURe)05016LoSQI: a validated pediatric localized scleroderma quality-of-life PRO, capturing four domains, now prototype-ready for adults.Technology TypeDigital HealthTechnology SubtypeHealthcare DeliveryTherapeutic AreasImmunologyMusculoskeletalTherapeutic IndicationsOtherTagsAutoimmuneLead InventorChristina ZiglerAll Tech InnovatorsKaveh ArdalanSuzanne LaneKathryn Seraphin TorokDate Submitted2019-06-19
Proteomic Biomarkers of Sepsis in Elderly Patients02712Proteomic biomarkers reveal age- and outcome-related protein changes to guide sepsis risk, therapy, and diagnosis in elderly patients.Technology TypeDiagnostic/AssayTechnology SubtypeBiomarkerTherapeutic AreasImmunologyInfectious DiseaseTherapeutic IndicationsSepsisLead InventorRena RobinsonDepartmentChemistryAll Tech InnovatorsDerek C. AngusZhiyun CaoJohn A. Kellum JrDate Submitted2012-03-09
Eomes fl/fl Mice02596Engineered Eomes floxed mice enable in vivo study of Eomes function, with research tool IP status for investigators.Technology TypeLife Science Research ToolTechnology SubtypeAnimal ModelTherapeutic AreasImmunologyLead InventorBinfeng LuDepartmentMed-ImmunologyAll Tech InnovatorsBinfeng LuDate Submitted2011-10-18
Degradable Osteosensor: Novel Degradable CNT-based Impedimetric Biosensors for Bone Marker Detection03000Degradable CNT-based impedimetric sensor detects bone resorption markers; biodegradable, home-use osteosense enables in vivo monitoring.Technology TypeMedical DeviceTechnology SubtypeImplantable Medical DeviceTherapeutic AreasImmunologyMusculoskeletalTherapeutic IndicationsRheumatoid arthritisOsteoporosisBone metabolismTagsAgingBiomaterialCoatingLead InventorPrashant KumtaDepartmentBioengineeringAll Tech InnovatorsPrashant N. KumtaMitali S. PatilMadhumati RamanathanTechnology Readiness Level3. Prototype developmentDate Submitted2013-03-04CollectionsRegenerative MedicineWomen's & Reproductive Health
Controlled Release Formulations for Induction and Proliferation of Regulatory T Cells02616Controlled release IL-2, TGF-β, and rapamycin formulations induce human regulatory T cells in vitro, enabling targeted in vivo expansion.Technology TypeTherapeutic ModalityTechnology SubtypeCell Therapy - T CellTherapeutic AreasImmunologyOncologyTherapeutic IndicationsSolid tumorLymphomaLeukemiaTagsAutoimmuneImmuno-oncologyLead InventorSteven LittleDepartmentEngr-Dept Chairperson's OfficeAll Tech InnovatorsSiddharth JhunjhunwalaSteven R. LittleGiorgio RaimondiTechnology Readiness Level2. Initial proof of concept, in-vitroDate Submitted2011-11-10CollectionsCell & Gene Therapy
T Cell Receptors Targeting Defective DNA Repair Proteins04988Engineered T cells express two TCRs targeting mutated DNA repair proteins, offering mutation-specific cancer immunotherapy.Technology TypeTherapeutic ModalityTechnology SubtypeCell Therapy - T CellTherapeutic AreasImmunologyOncologyTherapeutic IndicationsSolid tumorTagsImmuno-oncologyLead InventorUdai KammulaDepartmentMed-SurgeryAll Tech InnovatorsChetana BhaskarlaSmriti ChaurasiaUdai Shankar KammulaTechnology Readiness Level2. Initial proof of concept, in-vitroDate Submitted2019-05-10CollectionsCell & Gene TherapyWomen's & Reproductive Health
Low Passage Mesenchymal Stem Cell Cell Bank from Cadaveric Vertebral Bodies02247Cadaver vertebra-derived MSC bank enables rapid, large-scale expansion in bioreactors, reducing chromosomal risks and passage.Technology TypeLife Science Research ToolTechnology SubtypeCell LineTherapeutic AreasImmunologyTagsRegenerative medicineTissue engineeringLead InventorAlbert DonnenbergDepartmentMed-MedicineAll Tech InnovatorsAlbert D. DonnenbergLudovic ZimmerlinDate Submitted2010-06-09CollectionsRegenerative Medicine
One-step Gene Therapy for Duchenne Muscular Dystrophy04735Dual-cassette AAV gene therapy cures Duchenne by restoring dystrophin and suppressing inflammatory response in mice.Technology TypeTherapeutic ModalityTechnology SubtypeGene Therapy - AAVTherapeutic AreasImmunologyMusculoskeletalTherapeutic IndicationsInflammation - GeneralDuchenne muscular dystrophyTagsRare diseaseLead InventorBing WangDepartmentMed-MedicineAll Tech InnovatorsBing Wang MD, PhDTechnology Readiness Level3. Initial proof of concept, in-vivoDate Submitted2018-09-19CollectionsCell & Gene TherapyRare Diseases
Reagent Mouse for 15-Lipoxygenase-1 Enzyme Study Examines the Efficacy of the Therapeutic Compounds00920Reagent mouse models 15-LO-1 to test novel cancer and inflammatory therapies, enabling preclinical efficacy screening.Technology TypeLife Science Research ToolTechnology SubtypeAnimal ModelTherapeutic AreasImmunologyOncologyTherapeutic IndicationsInflammation - GeneralLead InventorUddhav KelavkarDepartmentMed-MedicineAll Tech InnovatorsThomas ElingUddhav Prabhakar KelavkarDate Submitted2004-02-11CollectionsWomen's & Reproductive Health
